产品名称:Anti-Rarres3/TIG3抗体,荧光素标记的视黄酸受体应答蛋白3抗体
中文名称:FITC标记的视黄酸受体应答蛋白3抗体
英文名称:Anti-Rarres3/TIG3/FITC
产品编号:BYK-1917R-FITC
产品别名:Retinoic acid receptor responder protein 3; HRASLS4; MGC8906; RAR responsive protein TIG3; Retinic acid inducible gene 1; Retinoic acid receptor responder (tazarotene induced) 3; Retinoid inducible gene 1 protein; RIG 1; rig1; Tazarotene induced gene 3 protein; TIG 3; TIG3; p18H-rev 107; Group XVI phospholipase A2; HRAS-like; rCG47447; HRSL4_HUMAN; HRAS-like suppressor 4; HRSL4; RAR-responsive protein TIG3; Retinoid-inducible gene 1 protein.
本公司另供应“FITC标记的视黄酸受体应答蛋白3抗体”的其他标记有:Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
产品规格:100ug
产品浓度: 2mg/1ml
亚 型:IgG
纯化方法:affinity purified by Protein A
储 存 液:0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品类型:标记一抗
抗体来源:Rabbit
克隆类型:polyclonal
保存条件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Anti-Rarres3/TIG3抗体,荧光素标记的视黄酸受体应答蛋白3抗体技术说明,产品推荐,由于篇幅原因,更多信息请来电咨询:
Anti-DCP/FITC 荧光素标记异常凝血酶原/脱-γ-羧基凝血酶原抗体IgG
Anti-DCX/FITC 荧光素标记双皮质素抗体IgG
Anti-DDB1/FITC 荧光素标记损伤DNA结合蛋白1抗体IgG
Anti-DDB2/FITC 荧光素标记损伤DNA结合蛋白2抗体IgG
Anti-DDC/FITC 荧光素标记多巴胺脱羧酶抗体IgG
Anti-DEC-205/CD205/Ly75/FITC 荧光素标记CD205抗体IgG
Anti-Dectin-1/CLECSF12/CLEC7A/FITC 荧光素标记C型凝集素结构域家族7成员A抗体IgG
Anti-Dectin-2/CLECSF10/CLEC6A/FITC 荧光素标记C型凝集素结构域家族6成员A抗体IgG
Anti-Defensin β1/FITC 荧光素标记防御素β1抗体IgG
Anti-Defensin β2/beta-defensin 2/BD-2(mouse) /FITC 荧光素标记防御素β2抗体IgG
Anti-Defensin β1/FITC 荧光素标记防御素β1抗体IgG
Anti-Defensin β2/beta-defensin 2/BD-2(rat) /FITC 荧光素标记 防御素β2抗体(大鼠)IgG
Anti-Rarres3/TIG3抗体,荧光素标记的视黄酸受体应答蛋白3抗体产品介绍:
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008].